The Impact of Changing Antithrombotic Management in Patients With Atrial Fibrillation and Ischemic Cerebrovascular Events Despite Anticoagulation.
Ehab HarahshehOmer ElshaigiNour AlhayekSkye A BucknerJaxon K QuillenCumara B O'CarrollOana M DumitrascuPublished in: The Neurohospitalist (2024)
In this single center retrospective study of 185 patients with AF and AIS/TIA despite AC, changing AC or adding AP agents did not decrease the risk of ischemic cerebrovascular events.